CSMS #53300810
PGA UpdateLow urgency
Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code
CSMS # 53300810 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code
U.S. Customs and Border Protection sent this bulletin at 09/16/2022 08:34 AM EDT
CSMS # 53300810 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code
The Food and Drug Administration (FDA) has created a new Center for Drug Evaluation and Research (CDER) product code listed below. It is available immediately.
Product Code/Description
61F[][]63/Rifaximin (A-Bacterial Pt. I) (Not Antibiotic)
Please send any questions or concerns to the email address for the Product Code Builder Feedback:
PCBFeedback@fda.hhs.gov
For assistance with product code identification, the public may also refer to the
FDA Product Code Builder
.
Additional Information
Programs Affected:
ACE
PGAs Affected:
FDA